Cite
HARVARD Citation
Stirrup, O. et al. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI). Journal of infectious diseases. pp. 1877-1881. [Online].